All Stories

  1. Relationship of Oxidative Stress as a Link between Diabetes Mellitus and Major Depressive Disorder
  2. Efficacy of Celecoxib adjunct treatment on bipolar disorder: systematic review and meta-analysis
  3. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder
  4. Resilience Dysregulation in Major Depressive Disorder: Focus on Glutamatergic Imbalance and Microglial Activation
  5. Frontiers in Drug Discovery
  6. Ketamine and Glutamatergic Compounds: Exploring Biomarkers and Mechanisms Related to Rapid Antidepressant Action
  7. The Search For Novel Antidepressants
  8. Immune System Modulators with Antidepressant Effects: Evidence from Animal Models
  9. Prevention of Memory Impairment and Neurotrophic Factors Increased by Lithium in Wistar Rats Submitted to Pneumococcal Meningitis Model
  10. Tools for studying drug transport and metabolism in the brain
  11. New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs
  12. Activity of Krebs cycle enzymes in mdx mice
  13. mTOR signaling in the neuropathophysiology of depression
  14. Staging Models and Functional Outcomes in Bipolar Disorder: Clinical Implications
  15. Treatment-resistant mood disorders
  16. Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine
  17. Role of Microglial Activation in the Pathophysiology of Bacterial Meningitis
  18. Cognitive Dysfunction in Depression: Lessons Learned from Animal Models
  19. Translational Research in Bipolar Disorders
  20. Does Infection-Induced Immune Activation Contribute to Dementia?
  21. Behavioral Responses in Animal Model of Congenital Muscular Dystrophy 1D
  22. Anxiety disorders are associated with quality of life impairment in patients with insulin-dependent type 2 diabetes: a case-control study
  23. Effects of chronic administration of fenproporex on cognitive and non-cognitive behaviors
  24. Protection of Blood Brain Barrier Integrity and Modulation of Inflammatory Mediators During Treatment of Pneumococcal Meningitis with Daptomycin or Ceftriaxone
  25. MAPK signaling correlates with the antidepressant effects of ketamine
  26. Neuroimmunomodulation in Depression: A Review of Inflammatory Cytokines Involved in this Process
  27. Neonatal Escherichia coli K1 meningitis causes learning and memory impairments in adulthood
  28. Increased on oxidative brain injury in the diabetic rats following sepsis
  29. Effects of Organoselenium Compounds on Early and Late Brain Biochemical Alterations in Sepsis-Survivor Rats
  30. Erythropoietin prevents cognitive impairment and oxidative parameters in Wistar rats subjected to pneumococcal meningitis
  31. The role of mTOR in depression and antidepressant responses
  32. Effects of tamoxifen on tricarboxylic acid cycle enzymes in the brain of rats submitted to an animal model of mania induced by amphetamine
  33. Sepsis in the Central Nervous System and Antioxidant Strategies with Nacetylcysteine, Vitamins and Statins
  34. Omega-3 fatty acids alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration
  35. Inflammation biomarkers and delirium in critically ill patients
  36. Oxidative stress and aging: correlation with clinical parameters
  37. Inhibition of indoleamine 2,3-dioxygenase prevented cognitive impairment in adult Wistar rats subjected to pneumococcal meningitis
  38. Il1-β Involvement in Cognitive Impairment after Sepsis
  39. Effects of sodium butyrate in animal models of mania and depression
  40. Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics
  41. Evaluation of acetylcholinesterase in an animal model of mania induced by d-amphetamine
  42. Acute Brain Inflammation and Oxidative Damage Are Related to Long-Term Cognitive Deficits and Markers of Neurodegeneration in Sepsis-Survivor Rats
  43. Methylphenidate treatment causes oxidative stress and alters energetic metabolism in an animal model of attention-deficit hyperactivity disorder
  44. Late brain alterations in sepsis-survivor rats
  45. Correlation of Acute Phase Inflammatory and Oxidative Markers With Long-term Cognitive Impairment in Sepsis Survivors Rats
  46. Evaluation of acetylcholinesterase activity and behavioural alterations induced by ketamine in an animal model of schizophrenia
  47. β-Carboline harmine reverses the effects induced by stress on behaviour and citrate synthase activity in the rat prefrontal cortex
  48. Attenuation of cognitive impairment by the nonbacteriolytic antibiotic daptomycin in Wistar rats submitted to pneumococcal meningitis
  49. The quest for better diagnosis: DSM-5 or RDoC?
  50. Central Nervous System Involvement in the Animal Model of Myodystrophy
  51. Methylphenidate treatment affects mitogen-activated protein kinase activation in the striatum of young rats
  52. Effects of sodium butyrate on oxidative stress and behavioral changes induced by administration of d-AMPH
  53. Methylphenidate Treatment Leads to Abnormalities on Krebs Cycle Enzymes in the Brain of Young and Adult Rats
  54. In vitroeffect of antipsychotics on brain energy metabolism parameters in the brain of rats
  55. Biological Mechanisms Underlying Neuroprogression in Bipolar Disorder
  56. Animal models in psychiatry
  57. Animal models as tools to study the pathophysiology of depression
  58. Contributions of animal models to the study of mood disorders
  59. Brain markers of neurodegeneration in sepsis survivor rats
  60. Sepsis-associated brain dysfunction in critically ill patients
  61. Epidemiological profile of suicide in the Santa Catarina Coal Mining Region from 1980 to 2007
  62. Evaluation of behavioral and neurochemical changes induced by ketamine in rats: Implications as an animal model of mania
  63. Behavioral changes and brain energy metabolism dysfunction in rats treated with methamphetamine or dextroamphetamine
  64. Caspase-3 Mediates In Part Hippocampal Apoptosis in Sepsis
  65. Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients
  66. Effects of maintenance electroshock on mitochondrial respiratory chain and creatine kinase activities in the rat brain
  67. Effects of alpha-lipoic acid in an animal model of mania induced byd-amphetamine
  68. Long-term decrease in immediate early gene expression after electroconvulsive seizures
  69. The administration of olanzapine and fluoxetine has synergistic effects on intracellular survival pathways in the rat brain
  70. Differential effects of escitalopram administration on metabolic parameters of cortical and subcortical brain regions of Wistar rats
  71. Antioxidant treatment prevents cognitive impairment and oxidative damage in pneumococcal meningitis survivor rats
  72. Brain energy metabolism is increased by chronic administration of bupropion
  73. Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats
  74. Imipramine treatment reverses depressive-like behavior in alloxan-diabetic rats
  75. Early life stress exacerbates cognitive dysfunction induced by d-amphetamine: amelioration by valproic acid
  76. Decreased BDNF levels in amygdala and hippocampus after intracerebroventricular administration of ouabain
  77. Brain-derived neurotrophic factor plasma levels are associated with mortality in critically ill patients even in the absence of brain injury
  78. Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats
  79. Olanzapine plus fluoxetine treatment alters mitochondrial respiratory chain activity in the rat brain
  80. Behavioral and neurochemical effects of sodium butyrate in an animal model of mania
  81. Effects of acute and chronic treatment elicited by lamotrigine on behavior, energy metabolism, neurotrophins and signaling cascades in rats
  82. Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain
  83. Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats
  84. Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants
  85. Mitochondrial respiratory chain activity in an animal model of mania induced by ouabain
  86. Neuroanatomical Profile of Antimaniac Effects of Histone Deacetylases Inhibitors
  87. Traffic of leukocytes and cytokine up-regulation in the central nervous system in sepsis
  88. Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine
  89. Eating disorders among health science students at a university in southern Brazil
  90. Effect of chronic administration of ketamine on the mitochondrial respiratory chain activity caused by chronic mild stress
  91. Brain energy metabolism parameters in an animal model of diabetes
  92. Aversive memory in sepsis survivor rats
  93. Agomelatine in the treatment of social anxiety disorder
  94. Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus
  95. Role of oxidative stress in the pathophysiology of bipolar disorder
  96. Intracerebroventricular ouabain administration induces oxidative stress in the rat brain
  97. Low dose dexamethasone reverses depressive-like parameters and memory impairment in rats submitted to sepsis
  98. DNA damage after intracerebroventricular injection of ouabain in rats
  99. Anti-HIV Drugs Nevirapine and Efavirenz Affect Anxiety-Related Behavior and Cognitive Performance in Mice
  100. Evaluation of brain creatine kinase activity in an animal model of mania induced by ouabain
  101. Inhibition of Mitochondrial Respiratory Chain in the Brain of Adult Rats After Acute and Chronic Administration of Methylphenidate
  102. Methylphenidate treatment increases Na+, K+-ATPase activity in the cerebrum of young and adult rats
  103. RIVASTIGMINE REVERSES HABITUATION MEMORY IMPAIRMENT OBSERVED IN SEPSIS SURVIVOR RATS
  104. Depressive-Like Parameters in Sepsis Survivor Rats
  105. Oxidative Mechanisms of Brain Dysfunction During Sepsis
  106. Cognitive Impairment in the Septic Brain
  107. Striatum brain-derived neurotrophic factor levels are decreased in dystrophin-deficient mice
  108. Phosphoinositide 3-kinase is required for bombesin-induced enhancement of fear memory consolidation in the hippocampus
  109. Na+,K+-ATPase activity in an animal model of mania
  110. Ketamine induces rapid onset of antidepressant action: neurophysiological biomarkers as predictors of effect
  111. Mangifera indica extract (Vimang) impairs aversive memory without affecting open field behaviour or habituation in rats
  112. Reply to Kaufman
  113. Peripheral nucleotide hydrolysis in rats submitted to a model of electroconvulsive therapy
  114. Memory-enhancing treatments reverse the impairment of inhibitory avoidance retention in sepsis-surviving rats
  115. Early antibiotic administration prevents cognitive damage induced by pneumococcal meningitis in Wistar rats
  116. Persistent cognitive damage in cloroquine-treated mice with cerebral malaria
  117. Oxidative damage in the rat hippocampus and cortex after meningitis induced by Streptococcus pneumoniae
  118. Perfil epidemiológico do suicídio no extremo oeste do estado de Santa Catarina, Brasil
  119. The Aqueous Extracts of Passiflora alata and Passiflora edulis Reduce Anxiety-Related Behaviors Without Affecting Memory Process in Rats
  120. The Septic Brain
  121. Time-dependent behavioral recovery after sepsis in rats
  122. Antipsychotic-induced oxidative stress in Rat Brain
  123. Acute treatment with low doses of memantine does not impair aversive, non-associative and recognition memory in rats
  124. Antioxidant Enzyme Activities Following Acute or Chronic Methylphenidate Treatment in Young Rats
  125. DARPP-32 and NCS-1 Expression is not Altered in Brains of Rats Treated with Typical or Atypical Antipsychotics
  126. Effect of antipsychotics on succinate dehydrogenase and cytochrome oxidase activities in rat brain
  127. Imipramine reverses the depressive symptoms in sepsis survivor rats
  128. Intense Exercise Induces Mitochondrial Dysfunction in Mice Brain
  129. Basic Fibroblast Growth Factor Prevents the Memory Impairment Induced by Gastrin-Releasing Peptide Receptor Antagonism in Area CA1 of the Rat Hippocampus
  130. Effects of Chronic Haloperidol and/or Clozapine on Oxidative Stress Parameters in Rat Brain
  131. Acute and subacute exposure to malathion impairs aversive but not non-associative memory in rats
  132. Influence of malathion on acetylcholinesterase activity in rats submitted to a forced swimming test
  133. Pharmacological Activity of Ruthenium Complexes trans-[RuCl2(L)4] (L = Nicotinic or i-Nicotinic acid) on Anxiety and Memory in Rats
  134. Mitochondrial Respiratory Dysfunction and Oxidative Stress after Chronic Malathion Exposure
  135. Decreased Creatine Kinase Activity Caused by Electroconvulsive Shock
  136. Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure
  137. Long Lasting Effects of Electroconvulsive Seizures on Brain Oxidative Parameters
  138. Malathion-induced Oxidative Stress in Rat Brain Regions
  139. Acute and chronic electroconvulsive shock in rats: Effects on peripheral markers of neuronal injury and glial activity
  140. Aversive Learning under Different Training Conditions: Effects of NMDA Receptor Blockade in Area CA1 of the Hippocampus
  141. Changes in Antioxidant Defense Enzymes after d-amphetamine Exposure: Implications as an Animal Model of Mania
  142. Effects of Milnacipran in Animal Models of Anxiety and Memory
  143. Lipid peroxidative damage on malathion exposure in rats
  144. Methylphenidate treatment induces oxidative stress in young rat brain
  145. Personalidade psicopática em uma amostra de adolescentes infratores brasileiros
  146. NMDA Receptors Mediate Consolidation of Contextual Memory in the Hippocampus after Context Preexposure
  147. Dexamethasone therapy and memory performance
  148. Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain
  149. Protective effect of N-acetylcysteine and deferoxamine on carbon tetrachloride-induced acute hepatic failure in rats
  150. Effects of Gabapentin on Anxiety Induced by Simulated Public Speaking
  151. Consolidação da memória e estresse pós-traumático
  152. Is it time to conclude that NMDA antagonists have failed?
  153. USE AND MISUSE OF BENZODIAZEPINES IN BRAZIL: A REVIEW
  154. MAPK and memory
  155. PATOGÊNESE DA ENCEFALOPATIA HEPÁTICA - UM PAPEL PARA OS RECEPTORES DE BENZODIAZEPÍNICOS ?
  156. Further evidence for the involvement of a hippocampal cGMP/cGMP-dependent protein kinase cascade in memory consolidation